Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: Ciprofloxacin 750 mg BID versus clarithromycin 500 mg BID

Antonio Anzueto, Michael S. Niederman, Glenn S. Tillotson

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Fingerprint Dive into the research topics of 'Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: Ciprofloxacin 750 mg BID versus clarithromycin 500 mg BID'. Together they form a unique fingerprint.

Medicine & Life Sciences